Form 4: TriSalus Life Sciences Executive Sells Shares to Cover Tax Obligations

Bryan F. Cox, Chief Scientific & Manufacturing Officer at TriSalus Life Sciences, sold 314 shares of common stock to cover tax obligations related to vested restricted stock units.

Summary

• Bryan F. Cox, the Chief Scientific & Manufacturing Officer of TriSalus Life Sciences, sold 314 shares of the company's common stock on October 5, 2024.
• The sale was executed at a price of $4.44 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of 4,127 restricted stock units granted on May 19, 2023.
• Following the transaction, Mr. Cox directly owns 86,382 shares of TriSalus Life Sciences common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for an executive to cover tax obligations. It is neither positive nor negative for the company's outlook.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• The number of shares sold is relatively small compared to the total holdings of the executive, which is typical for these types of transactions.
• The price of $4.44 per share is a reflection of the current market value of the stock at the time of the transaction.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is not expected to be significant.

Key Dates

Keywords

TriSalus Life Sciences, insider trading, stock sale, Form 4, executive, Bryan F. Cox, tax obligations, restricted stock units